guronelogoh.blogspot.com
Leaders of , a firm researchiny and developing tests to scree forbreast cancer, said the New York-basec 's grant, which will be given over the next two will help expand the studu of a potentially new screening test for breastr cancer already under way at the , "We are turning the corner from research and development to a producft company," said Ginette CEO of A&G. "We want to get to a phase of havinga product.
" Serrero said the companhy plans to use the funding, alont with some of its own cash, on additionalk clinical trials of the diagnostic The expanded trial could involvr several cancer centers in the Earlier this year, the company, which employs 18, receivee $2.2 million in fundinbg from venture capital. Founded in 2000, A& G has raised more than $14 million in capital, includingt investments by Boston-based and the . The company also has submitted a diagnostic test kit for breast cancer to thefor approval. Serrerol said that although there is no immediate planfor expansion, the compangy could grow as it brings products to market.
By Avon Foundation had awarded $500 million in grantds internationally to programs and efforts including breastrcancer awareness. The organization typicallt fundsnonprofit efforts, and its investment in A&G is amonvg the few private company grants awardedc in the past few years.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment